ITW Dr Ari Gargir - Founder-CEO RedC Biotech

What If We Could Have An Unlimited Source of Universal Red Blood Cells?

RedC Biotech, a pioneering company founded in 2015, is set to revolutionize the medical industry and save millions of lives with its cutting-edge innovation. With an exclusive partnership with Technion, they are on a mission to bring to market an unlimited source of universal blood red cells, derived from human stem cells.

Backed by over 50 patents originating from the prestigious Technion, RedC Biotech's innovative process promises to fulfil the unmet need for red blood cell transfusions and eliminate the shortage that claims the lives of over 2 million people annually. This is a significant step toward eradicating the challenges faced by traditional human donor red blood cell transfusions.

RedC Biotech envisions a future where donor-free, universal red blood cells are produced at an industrial scale, addressing the pressing global market demand that surpasses a staggering $50 billion.

Dr Ari Gargir is the Founder and CEO of RedC Biotech, developing an industrial process for production of life saving universal red blood cells. For over 20 years, Ari led R&D and product development teams in various global and startup companies in the areas of biomedical research tools, pharmaceutical development and diagnostics. Ari Gargir holds a PhD in Microbiology from the Tel Aviv University and is an alumnus of the International Space University.

https://www.linkedin.com/in/ari-gargir-7107035/

https://www.redcbiotech.com/

Hosted on Acast. See acast.com/privacy for more information.